-
Binance says resuming withdrawals after major hack
-
Shnaider beats Fernandez to win Tokyo title
-
Divided Bulgaria votes in tense presidential runoff
-
Winds of change: Laos looks up for renewables push
-
Trump says US looking 'closely' at report Nvidia CEO target of China spy plot
-
Sri Lanka's war widows and the long search for the missing
-
Maxey scores 38 to lead Sixers 'fighters' to another comeback win
-
'Air-con nation' Singapore eyes alternatives to cool down
-
Valkyries defeat Dream to capture first WNBA crown
-
US judge dismisses Trump lawsuit against Wall Street Journal over Epstein letter
-
'Seen and heard': Uruguay neighborhood places hopes in pope
-
Slave or not? US gallery shows early photos of African Americans
-
Spewing US election falsehoods, AI chatbots face scrutiny
-
France's Aymoz wins Skate Canada men's crown
-
EU's new levy on parcels kicks in
-
Pope Leo readies for 'intense' South America homecoming
-
Ocon denies reports of altercation after being dumped by Haas
-
Antonelli admits to feeling tense of eve of potential F1 title decider
-
Hamilton says love of racing keeps him young
-
FBI says North Korea behind $6 billion crypto theft from Binance
-
'Disgraceful' Australia face reckoning after South Africa humbling
-
'Canelo' Alvarez wins back WBC title from Mbilli in Riyadh
-
Sovereignty wins Breeders' Cup Classic, Benvenuto Cellini triumphs in Turf for O'Brien
-
'Canelo' Alvarez wins back WBC title from Mbilli
-
Hamilton takes record 105th pole and first for Ferrari, as Antonelli lurks
-
Sovereignty wins Breeders' Cup Classic
-
German rioters loot shops as 'Gen Z' demos turn ugly
-
Hamilton grabs pole position for Mexican Grand Prix
-
Barca hammer Alaves to retain Liga top spot
-
Benvenuto Cellini wins Breeders' Cup Turf
-
UK king to address Commonwealth with 'unflinching honesty' amid slavery focus
-
Roma thrash Udinese ahead of Milan derby
-
US judge dismisses Trump lawsuit against Wall Steet Journal over Epstein letter
-
Kane laments Dortmund draw after 'incredible high' of Ballon d'Or
-
Polish president holds crisis talks in court standoff
-
Spanish village holds memorial mass for train crash victims
-
NFL to review new allegations against Packers' Jacobs: reports
-
Israeli protesters demand opposition ally with Arab parties to oust Netanyahu
-
Le Havre owners sack coach after PSG thrashing
-
De Minaur upsets Zverev and will face Alcaraz in Vienna final
-
De Minaur upsets Zverev and will face Alacaraz in Vienna final
-
Kane misses penalty as Bayern held by Dortmund
-
German police, protesters clash after 'Gen Z' demos
-
In Mexico City, Day of the Dead parade inspired by 007
-
Fresh frustration for Maresca as Man City lose to Brighton
-
Rubio flags challenges in finding consensus as G20 talks wrap
-
Norris fastest ahead of Antonelli in final Mexico practice
-
Zaman's century foils Sri Lanka as Pakistan win tri-series
-
Hammers boss Nuno under pressure after West Brom loss
-
Bordeaux edge Bayonne to keep pressure on Toulouse
Pace Life Sciences Completes Successful EMA GMP Inspection at New Jersey Facility
Inspection outcome supports renewal of GMP certificate at Lebanon site providing pharmaceutical analytical testing and development support.
MINNEAPOLIS, MN / ACCESS Newswire / October 28, 2026 / Pace® Life Sciences, a division of Pace®, a Science and Technology Company, has completed a European Medicines Agency (EMA) Good Manufacturing Practice (GMP) inspection at its Lebanon, New Jersey facility as part of its EU GMP certificate renewal process. Pace® Life Sciences is a U.S.-based, FDA-registered GMP analytical testing laboratory and full-service contract development and manufacturing organization (CDMO).
The inspection conducted on October 13 and 14, 2026, assessed the site's quality systems and laboratory operations, including stability programs, equipment qualification, sample receipt and management, employee training, corrective and preventive actions (CAPA), analytical procedures, data packages, and container closure integrity testing activities. A renewed EU GMP certificate is expected to be issued.
"Our customers rely on defensible analytical data to bring safe, effective therapies to patients worldwide," said Lou Forcellini, VP of Quality Assurance at Pace® Life Sciences. "This achievement reflects our team's commitment to operational excellence and reinforces our ability to operate within rigorous international regulatory frameworks while delivering the reliable, high-quality data our clients depend on."
"The successful EMA inspection further demonstrates the strength of our quality systems and the depth of regulatory expertise at our Lebanon site," said Amanda Yoakum, Senior Director and Site Lead. "As pharmaceutical development and supply chains become increasingly global, we remain committed to helping our clients navigate complex regulatory expectations, advance their programs with confidence, and ultimately support the safety and efficacy of therapies reaching patients around the world."
The 40,000-square-foot facility provides analytical testing and development support for pharmaceutical and biopharmaceutical companies including container closure integrity testing (CCIT), stability testing, analytical method development and validation, and microbiology testing.
Pace® is a portfolio company of Leonard Green & Partners and Los Angeles-based Aurora Capital Partners.
ABOUT PACE® LIFE SCIENCES
Pace® Life Sciences delivers scientific certainty to pharmaceutical and biopharmaceutical clients, developing life-changing therapies. From early R&D and clinical trial materials production to analytical testing and commercial-stage support, Pace® works closely with clients to reduce risk, anticipate challenges, and keep critical programs moving forward. Across its network of U.S.-based facilities, Pace® also provides regulatory, quality, and laboratory operations support, helping clients strengthen compliance, and improve internal processes to address evolving business and scientific needs. By combining expertise, responsive service, and a partnership-led approach, Pace® helps clients move forward with greater clarity and confidence. Learn more at PACELIFESCIENCES.COM
Media Contact:
Brooke Schwartzel, Brand & Communications Manager
[email protected]
Jennifer Hernández, Corporate Communications Specialist
[email protected]
SOURCE: Pace® Analytical
View the original press release on ACCESS Newswire
P.Mathewson--AMWN